Farber, Harold J.; Glauber, James - In: Disease Management and Health Outcomes 14 (2006) 6, pp. 353-368
As treatment for moderate to severe persistent asthma, inhaled corticosteroid drugs combined with long-acting beta-adrenoceptor agonists are being marketed in a single inhaler device. These combination products have important benefits (e.g. convenience, improved adherence, and improved...